Marginal Revolution
Subscribe
Cover photo

Why Doesn't the United States Have Test Abundance?

by Alex Tabarrok

Marginal Revolution

25 Aug 2021

We have vaccine abundance in the United States but not test abundance. Germany has test abundance. Tests are easily available at the supermarket or the corner store and they are cheap, five tests for 3.75 euro or less than a dollar each. Billiger! In Great Britain you can get a 14 pack for free. The Canadians are also distributing packs of tests to small businesses for free to test their employees.

In the United States, the FDA has approved less than a handful of true at-home tests and, partially as a result, they are expensive at $10 to $20 per test, i.e. more than ten times as expensive as in Germany. Germany has approved over 50 of these tests including tests from American firms not approved in the United States. The rapid tests are excellent for identifying infectiousness and they are an important weapon, alongside vaccines, for controlling viral spread and making gatherings safe but you can't expect people to use them more than a handful of times at $10 per use.

We ought to have testing abundance in the US and not lag behind Europe, the UK and Canada. As usual, I say if it's good enough for the Germans it's good enough for me.

Addendum: The excellent Michael Mina continues to bang the drum.

Subscribe for free to Marginal Revolution
By subscribing, you agree to share your email address with Marginal Revolution to receive their original content, including promotions. Unsubscribe at any time. Meta will also use your information subject to the Bulletin Terms and Policies

More from Marginal Revolution
See all

And yet more assorted links

TC
Today

How polarized are Americans?

TC
25 May

Did the NYT get Haiti right?

TC
25 May
Comments
Subscribe with Facebook to comment

0 comments

Share quoteSelect how you’d like to share below
Share on Facebook
Share to Twitter
Send in WhatsApp
Share on LinkedIn
Privacy  ·  Terms  ·  Cookies
© Meta 2022
Discover fresh voices. Tune into new conversations. Browse all publications